Advanced BioMedical Technologies
(OTC) ABMT
Advanced BioMedical Technologies Financials at a Glance
Market Cap
$40,000
Revenue (TTM)
$400.13K
Net Income (TTM)
$491.76K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-3.06 (Low)
Dividend
$0.00
Beta (Volatility)
-3.06 (Low)
Price
$0.00
Volume
150
Open
$0.00
Price
$0.00
Volume
150
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-3.06 (Low)
Price
$0.00
Volume
150
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
ABMT News
ABMT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Advanced BioMedical Technologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareCEO
Hui Wang
Website
www.abtlafleur.comHeadquarters
New York City, NY 10166, US
ABMT Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
-66%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
2%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$40.00K
Shares Outstanding
100.00M
Volume
150
Short Interest
0.00%
Avg. Volume
55.738
Financials (TTM)
Gross Profit
$221.88K
Operating Income
$179.88K
EBITDA
$166.01K
Operating Cash Flow
$734.53K
Capital Expenditure
$0.00
Free Cash Flow
$734.53K
Cash & ST Invst.
$4.84K
Total Debt
$6.81M
Advanced BioMedical Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.94K
-2843.9%
Gross Profit
$7.29K
-5234.5%
Gross Margin
1.48%
N/A
Market Cap
$40.00K
N/A
Market Cap/Employee
$2.35K
N/A
Employees
17
N/A
Net Income
$189.79K
+4.5%
EBITDA
$103.96K
+5.8%
Quarterly Fundamentals
Net Cash
$7.09M
-184370.1%
Accounts Receivable
$0.00
-100.0%
Inventory
$239.93K
+27.1%
Long Term Debt
$0.00
N/A
Short Term Debt
$7.09M
+32667.8%
Return on Assets
-1.30%
N/A
Return on Invested Capital
2.27%
N/A
Free Cash Flow
$170.31K
-105.4%
Operating Cash Flow
$170.31K
-110.3%